Study comparing the pharmacokinetics of of 2.0 mg intranasal and intramuscular naloxone HCl administration and the impact of vasoconstrictor use on the bioavailability of Iitranasal naloxone HCl
Latest Information Update: 24 Sep 2016
At a glance
- Drugs Naloxone (Primary) ; Naloxone
- Indications Rhinitis
- Focus Pharmacokinetics
- 24 Sep 2016 New trial record